Platinum is essential in neoadjuvant treatment of triple negative breast cancer: A network meta-analysis

被引:0
|
作者
Li, Junjie
Chen, Li
Tan, Wei
Qi, Fang
Zhang, Yang
Wang, Zhonghua
Shao, Zhimin
机构
关键词
D O I
10.1158/1538-7445.SABCS21-P2-12-19
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P2-12-19
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Platinum is essential in neoadjuvant treatment of triple-negative breast cancer: a network meta-analysis
    Li, Junjie
    Chen, Li
    Tan, Wei
    Qi, Fang
    Zhang, Yang
    Wang, Zhonghua
    Shao, Zhimin
    CANCER BIOLOGY & MEDICINE, 2022, 19 (05) : 742 - 754
  • [2] Platinum is essential in neoadjuvant treatment of triple-negative breast cancer: a network meta-analysis
    Junjie Li
    Li Chen
    Wei Tan
    Fang Qi
    Yang Zhang
    Zhonghua Wang
    Zhimin Shao
    Cancer Biology & Medicine, 2022, 19 (05) : 742 - 754
  • [3] Platinum dose in neoadjuvant therapy for triple-negative breast cancer: A systematic review and network meta-analysis
    Petrelli, Fausto
    Ghidini, Antonio
    Rea, Carmen
    Parati, Maria Chiara
    Borgonovo, Karen
    Ghidini, Michele
    Ruatta, Fiorella
    Zaniboni, Alberto
    Luciani, Andrea
    Garrone, Ornella
    Tomasello, Gianluca
    CURRENT PROBLEMS IN CANCER, 2024, 50
  • [4] Neoadjuvant therapy in triple-negative breast cancer: A systematic review and network meta-analysis
    Lin, Ying-Yi
    Gao, Hong-Fei
    Yang, Xin
    Zhu, Teng
    Zheng, Xing-xing
    Ji, Fei
    Zhang, Liu-Lu
    Yang, Ci-Qiu
    Yang, Mei
    Li, Jie-Qing
    Cheng, Min-Yi
    Wang, Kun
    BREAST, 2022, 66 : 126 - 135
  • [5] A meta-analysis of the effect and safety of platinum-based neoadjuvant chemotherapy in treatment of resectable triple-negative breast cancer
    Feng, Wuna
    He, Yujing
    Xu, Jingsi
    Zhang, Hongya
    Si, Yuexiu
    Xu, Jiaxuan
    Li, Shengzhou
    ANTI-CANCER DRUGS, 2022, 33 (01) : E52 - E60
  • [6] A meta-analysis of platinum-based neoadjuvant chemotherapy versus standard neoadjuvant chemotherapy for triple-negative breast cancer
    Wang, Dong
    Feng, Jiafu
    Xu, Bei
    FUTURE ONCOLOGY, 2019, 15 (23) : 2779 - 2790
  • [7] Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis
    Poggio, F.
    Bruzzone, M.
    Ceppi, M.
    Ponde, N. F.
    La Valle, G.
    Del Mastro, L.
    de Azambuja, E.
    Lambertini, M.
    ANNALS OF ONCOLOGY, 2018, 29 (07) : 1497 - 1508
  • [8] Platinum-based neoadjuvant chemotherapy for triple-negative breast cancer: a systematic review and meta-analysis
    Li, Zhen-Yu
    Zhang, Zhen
    Cao, Xiao-Zhong
    Feng, Yun
    Ren, Sha-Sha
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (10)
  • [9] Platinum-based therapy for triple-negative breast cancer treatment: A meta-analysis
    Tian, Muyou
    Zhong, Yahua
    Zhou, Fuxiang
    Xie, Conghua
    Zhou, Yunfeng
    Liao, Zhengkai
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (03) : 720 - 724
  • [10] Efficacy and safety of neoadjuvant chemotherapy regimens for triple-negative breast cancer: a network meta-analysis
    Li, Yunhai
    Yang, Dejuan
    Chen, Ping
    Yin, Xuedong
    Sun, Jiazheng
    Li, Hongzhong
    Ren, Guosheng
    AGING-US, 2019, 11 (16): : 6286 - 6311